Life Sciences and Health Care

The Life Sciences and Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. Deloitte's global network engages with clients to develop innovative solutions to help them achieve their business missions.


Deloitte European Life Sciences Centre of Excellence

Life Sciences Centre of Excellence Deloitte Switzerland. 


Deloitte UK Centre for Health Solutions

The health services research arm of Deloitte United Kingdom.


PLM Governance & Organizational Alignment

PLM governance is a must in order to realise efficiency gains and not add additional cost due to unmanaged organization development.


Product Life Cycle Management in Life Sciences Industry

Focusing on Product Lifecycle Management (PLM) to cope with the future industry environment


Accounting and financial reporting update (March 2014)

Deloitte is pleased to present the life sciences industry’s fifth annual accounting and financial reporting update. This publication highlights specialized accounting and reporting considerations applicable to companies in this industry. 


Deloitte Analytics

Increased reliance on analytics is driving decision-making, behavioural change and collaboration in unprecedented ways.



Deloitte has extensive relationships with pharmaceutical companies across the whole spectrum of size and geography. 



Switzerland is one of the top biotechnology locations in Europe. Biotechnology remains a firm agenda item in the approach to drug development and Switzerland is leading the way. 


Medical devices

Switzerland is one of the leading Medtech locations globally. In relation to per capita Switzerland is the 2nd most important Medtech region worldwide.


Impact of austerity on European pharmaceutical policy and pricing

Deloitte U.K. Centre for Health Solutions report addresses current challenges faced by the pharmaceutical industry due to on-going austerity in Europe. 


Virtual health

Virtual health offers the potential to lower costs, reduce utilization, generate revenue and increase operational efficiency on the business side, while supporting care coordination and delivering better outcomes on the clinical side.




Opportunities in China’s pharmaceutical markets

As the world's next great market for patented drugs, companies who might have hesitated before now see that China is moving past its phase as a supply market for ingredients and generic finished drugs, and on to a new phase as the world's second-largest LSHC market within this decade.

Contact us

Contact us via our online form.

Key contact

Robert Reppas

Life Sciences Industry Leader

Key contact

Matthias Scherler

Partner, Public Sector

Key contact

Nico Kleyn

Partner, Consulting


Join the conversation

Social media connections to Deloitte's Life Sciences and Health Care practice. 


High value, high uncertainty

Europe’s biopharmaceutical industry faces one of the highest business risks among six key industry sectors, according to a new comparative study.


Key pricing and profitability trends for Life Sciences Companies

Discover the results of the survey conducted by Deloitte on pricing and profitability amongst senior executives from leading global life sciences companies. 


Serialisation isn’t optional

Protect your patients, Product Revenue and Brand
Reputation along your Supply Chain through


Product Packaging for life sciences

Discover innovative packaging initiatives to add value and contribute to revenue growth, branding and cost reduction.